Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sudden unexpected death in epilepsy: a local audit

P L Timmings1

  • 1Dept of Pharmacology and Therapeutics, University of Wales College of Medicine, Health Park, Cardiff, UK.

Seizure
|December 1, 1993
PubMed
Summary

Sudden unexpected death in epilepsy (SUDE) affects approximately 1 in 500 patients annually, with males and those with generalized tonic-clonic seizures being more susceptible. Further research is needed to accurately determine SUDE incidence and risk factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sudden unexpected death in epilepsy: is carbamazepine implicated?

Seizure·1998
Same author

Wernicke's encephalopathy presenting with blindness.

The New Zealand medical journal·1993
Same author

Juvenile myoclonic epilepsy.

BMJ (Clinical research ed.)·1992
Same author

Lamotrigine in primary generalised epilepsy.

Lancet (London, England)·1992
Same author

Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome.

European neurology·1992
Same author

Impairment of high-contrast visual acuity in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society·1992

Area of Science:

  • Neurology
  • Epilepsy Research
  • Public Health

Background:

  • Sudden unexpected death in epilepsy (SUDE) is an under-investigated cause of mortality.
  • Limited prospective studies exist on SUDE incidence and contributing factors.

Purpose of the Study:

  • To audit data from the Cardiff Epilepsy Unit to identify SUDE cases.
  • To analyze demographic and clinical characteristics of SUDE patients.
  • To compare SUDE patient profiles with the general epilepsy patient population.

Main Methods:

  • Retrospective audit of 7000 patient-treatment years at the Cardiff Epilepsy Unit.
  • Identification of 14 SUDE cases.
  • Comparison of SUDE cases with over 1820 other epilepsy patients.

Main Results:

  • SUDE incidence estimated at 1 in 500 patients per year.
  • Males were twice as likely to be affected as females.
  • SUDE patients were significantly more likely to have idiopathic generalized tonic-clonic seizures and use carbamazepine compared to other epilepsy patients.

Conclusions:

  • SUDE appears more prevalent in males with generalized tonic-clonic seizures, particularly those on carbamazepine.
  • Accurate identification and prospective studies are crucial for understanding SUDE.
  • Further research is needed to ascertain true incidence, risk factors, and causes of SUDE.

Related Experiment Videos